Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update Nanotech Investing
Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions Emerging Technology Investing
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 Nanotech Investing
Nextech3D.ai Achieves Milestone with 3D AI Modeling Profit Margins Hitting 80% in Q2 2024 Up From 30% in 2023 Emerging Technology Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
